Colgate-Palmolive Company (CL) Holdings Maintained by Lowe Brockenbrough & Co. Inc.
Lowe Brockenbrough & Co. Inc. continued to hold its stake in shares of Colgate-Palmolive Company (NYSE:CL) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 40,510 shares of the company’s stock at the close of the first quarter. Lowe Brockenbrough & Co. Inc.’s holdings in Colgate-Palmolive were worth $2,965,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in CL. TIAA CREF Investment Management LLC raised its stake in Colgate-Palmolive by 84.2% in the 1st quarter. TIAA CREF Investment Management LLC now owns 4,554,989 shares of the company’s stock valued at $333,380,000 after purchasing an additional 2,082,262 shares during the last quarter. Swiss National Bank raised its stake in Colgate-Palmolive by 22.2% in the 1st quarter. Swiss National Bank now owns 3,667,072 shares of the company’s stock valued at $268,393,000 after purchasing an additional 666,400 shares during the last quarter. Karp Capital Management Corp raised its stake in Colgate-Palmolive by 3,749.4% in the 1st quarter. Karp Capital Management Corp now owns 381,210 shares of the company’s stock valued at $27,901,000 after purchasing an additional 371,307 shares during the last quarter. Teachers Advisors LLC raised its stake in Colgate-Palmolive by 25.4% in the 1st quarter. Teachers Advisors LLC now owns 1,814,250 shares of the company’s stock valued at $132,785,000 after purchasing an additional 367,977 shares during the last quarter. Finally, Scopus Asset Management L.P. acquired a new position in Colgate-Palmolive in the 1st quarter valued at about $25,617,000. 73.16% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY WARNING: This piece of content was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/13/colgate-palmolive-company-cl-holdings-maintained-by-lowe-brockenbrough-co-inc.html.
Colgate-Palmolive Company (NYSE CL) traded up 0.01% during trading on Wednesday, reaching $71.96. The company’s stock had a trading volume of 566,609 shares. The stock’s 50-day moving average is $71.62 and its 200 day moving average is $73.32. Colgate-Palmolive Company has a 52-week low of $63.43 and a 52-week high of $77.27. The firm has a market capitalization of $63.39 billion, a price-to-earnings ratio of 26.74 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 21st. The company reported $0.72 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.72. Colgate-Palmolive had a return on equity of 3,121.95% and a net margin of 15.83%. The business had revenue of $3.83 billion for the quarter, compared to the consensus estimate of $3.89 billion. During the same period last year, the business earned $0.70 EPS. The firm’s revenue was down .5% compared to the same quarter last year. On average, analysts predict that Colgate-Palmolive Company will post $2.89 EPS for the current fiscal year.
In related news, CFO Dennis J. Hickey sold 73,872 shares of the firm’s stock in a transaction that occurred on Thursday, August 3rd. The stock was sold at an average price of $71.80, for a total value of $5,304,009.60. Following the transaction, the chief financial officer now directly owns 484,985 shares of the company’s stock, valued at approximately $34,821,923. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Justin Skala sold 74,374 shares of the firm’s stock in a transaction that occurred on Thursday, July 27th. The shares were sold at an average price of $72.51, for a total value of $5,392,858.74. Following the completion of the transaction, the chief operating officer now directly owns 97,177 shares in the company, valued at $7,046,304.27. The disclosure for this sale can be found here. Insiders sold a total of 221,802 shares of company stock worth $15,983,976 over the last three months. 1.02% of the stock is owned by company insiders.
Several research analysts recently weighed in on the stock. BidaskClub downgraded shares of Colgate-Palmolive from a “hold” rating to a “sell” rating in a research note on Saturday, June 24th. Deutsche Bank AG reissued a “hold” rating and issued a $75.00 target price on shares of Colgate-Palmolive in a research note on Monday, July 24th. Wells Fargo & Company reissued a “market perform” rating on shares of Colgate-Palmolive in a research note on Monday, July 24th. Jefferies Group LLC boosted their target price on shares of Colgate-Palmolive from $76.00 to $77.00 and gave the company a “hold” rating in a research note on Thursday, July 6th. Finally, Zacks Investment Research raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating and set a $83.00 price objective for the company in a research note on Tuesday, July 4th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus target price of $75.82.
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL).
Receive News & Stock Ratings for Colgate-Palmolive Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive Company and related stocks with our FREE daily email newsletter.